Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,587.32
-1,655.03(-3.29%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

American Oncology Network, Inc. (AONC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

3.5500

-0.0900

(-2.47%)

At close: 04:00PM EDT

3.5000

-0.05

(-1.41%)

After hours:

04:17PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	44.13M
Enterprise value	173.51M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.02
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	0.49
52-week change ³	-65.70%
S&P500 52-week change ³	26.27%
52-week high ³	39.6000
52-week low ³	3.5500
50-day moving average ³	5.1450
200-day moving average ³	7.2444

Share statistics

Avg vol (3-month) ³	11.33k
Avg vol (10-day) ³	18.42k
Shares outstanding ⁵	12.43M
Implied shares outstanding ⁶	12.43M
Float ⁸	2.19M
% held by insiders ¹	42.45%
% held by institutions ¹	1.02%
Shares short (30 Apr 2024) ⁴	21.29k
Short ratio (30 Apr 2024) ⁴	1.52
Short % of float (30 Apr 2024) ⁴	0.43%
Short % of shares outstanding (30 Apr 2024) ⁴	0.17%
Shares short (prior month 28 Mar 2024) ⁴	25.56k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-0.43%
Operating margin (ttm)	-5.94%

Management effectiveness

Return on assets (ttm)	-2.34%
Return on equity (ttm)	-54.35%

Income statement

Revenue (ttm)	1.28B
Revenue per share (ttm)	191.34
Quarterly revenue growth (yoy)	7.90%
Gross profit (ttm)	N/A
EBITDA	-4.67M
Net income avi to common (ttm)	-9.12M
Diluted EPS (ttm)	-1.3600
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	63.93M
Total cash per share (mrq)	6.03
Total debt (mrq)	132.87M
Total debt/equity (mrq)	187.91%
Current ratio (mrq)	1.64
Book value per share (mrq)	N/A

Cash flow statement

Operating cash flow (ttm)	-18.12M
Levered free cash flow (ttm)	19.11M